Evidence map›Paper›PMID 27023174›Full record

ArticleTranslational psychiatry2016

Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia.

J Costas, N Carrera, P Alonso, X Gurriarán, C Segalàs, E Real, C López-Solà, S Mas, P Gassó, L Domènech and 6 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. EEG microstate co-specificity in schizophrenia and obsessive-compulsive disorder.European archives of psychiatry and clinical neuroscience · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

J CostasGrupo de Xenética Psiquiátrica, Instituto de Investigación Sanitaria de Santiago, Complexo Hospitalario Universitario de Santiago de Compostela, Servizo Galego de Saúde, Santiago de Compostela, Spain.
N CarreraCentre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
P AlonsoOCD Clinical and Research Unit, Department of Psychiatry, Hospital de Bellvitge, Barcelona, Spain.
X GurriaránGrupo de Xenética Psiquiátrica, Instituto de Investigación Sanitaria de Santiago, Complexo Hospitalario Universitario de Santiago de Compostela, Servizo Galego de Saúde, Santiago de Compostela, Spain.
C SegalàsOCD Clinical and Research Unit, Department of Psychiatry, Hospital de Bellvitge, Barcelona, Spain.
E RealOCD Clinical and Research Unit, Department of Psychiatry, Hospital de Bellvitge, Barcelona, Spain.
C López-SolàOCD Clinical and Research Unit, Department of Psychiatry, Hospital de Bellvitge, Barcelona, Spain.
S MasCentro de Investigación Biomédica en Red de Salud Mental, Carlos III Health Institute, Madrid, Spain.
P GassóDepartment of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, Barcelona, Spain.
L DomènechGenomics and Disease Group, Centre for Genomic Regulation, Barcelona, Spain.
M MorellGenomics and Disease Group, Centre for Genomic Regulation, Barcelona, Spain.
I QuintelaGrupo de Medicina Xenómica, Universidade de Santiago de Compostela, Centro Nacional de Genotipado - Instituto Carlos III, Santiago de Compostela, Spain.
L LázaroCentro de Investigación Biomédica en Red de Salud Mental, Carlos III Health Institute, Madrid, Spain.
J M MenchónOCD Clinical and Research Unit, Department of Psychiatry, Hospital de Bellvitge, Barcelona, Spain.
X EstivillGenomics and Disease Group, Centre for Genomic Regulation, Barcelona, Spain.
Á CarracedoFundación Pública Galega de Medicina Xenómica, Servicio Galego de Saúde, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstituto de Investigación Sanitaria de Santiago · ESInstituto de Salud Carlos III · ESUniversitat de Barcelona · ESCentro de Investigación Biomédica en Red · ESCentro de Investigación Biomédica en Red de Salud Mental · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESFundación Pública Galega de Medicina Xenómica · ESHospital Universitari de Vic · ESInstitut d'Investigació Biomédica de Bellvitge · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common single-nucleotide polymorphisms (SNPs) account for a large proportion of the heritability of obsessive-compulsive disorder (OCD). Co-ocurrence of OCD and schizophrenia is commoner than expected based on their respective prevalences, complicating the clinical management of patients. This study addresses two main objectives: to identify particular genes associated with OCD by SNP-based and gene-based tests; and to test the existence of a polygenic risk shared with schizophrenia. The primary analysis was an exon-focused genome-wide association study of 370 OCD cases and 443 controls from Spain. A polygenic risk model based on the Psychiatric Genetics Consortium schizophrenia data set (PGC-SCZ2) was tested in our OCD data. A polygenic risk model based on our OCD data was tested on previous data of schizophrenia from our group. The most significant association at the gene-based test was found at DNM3 (P=7.9 × 10(-5)), a gene involved in synaptic vesicle endocytosis. The polygenic risk model from PGC-SCZ2 data was strongly associated with disease status in our OCD sample, reaching its most significant value after removal of the major histocompatibility complex region (lowest P=2.3 × 10(-6), explaining 3.7% of the variance). The shared polygenic risk was confirmed in our schizophrenia data. In conclusion, DNM3 may be involved in risk to OCD. The shared polygenic risk between schizophrenia and OCD may be partially responsible for the frequent comorbidity of both disorders, explaining epidemiological data on cross-disorder risk. This common etiology may have clinical implications.

Indexed as

Multifactorial InheritanceCase-Control StudiesDynamin IIIExonsFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMaleObsessive-Compulsive DisorderPolymorphism, Single NucleotideRiskSchizophreniaDynamin III

Identifiers

PMID27023174
PMCPMC4872458
OpenAlexW2324316373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.